Varex reports Q3 FY2022 revenue $214M, GAAP EPS $0.20; board adds Kathleen Bardwell

Varex Imaging Corp

2022-Q3 EPS reported $0.41 revenue$628,000,000

Revenue $214M, flat QoQ and +2% YoY; Medical segment flat, Industrial +8% YoY.
GAAP diluted EPS $0.20; non-GAAP diluted EPS $0.37; non-GAAP gross margin 35%.
Q4 FY2022 guidance: revenue $210M-$240M, non-GAAP EPS $0.25-$0.45.
Board appointed Kathleen L. Bardwell, former STERIS SVP Regulatory Affairs & Compliance, effective July 29, 2022.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kathleen L. Bardwell

Director

VREX · Varex Imaging Corp

Effective: 2022-07-29
Filed: August 2, 2022, 7:59 PM ET

appointed Kathleen L. Bardwell to serve on the Board for a term effective as of July 29, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen L. Bardwell was appointed as Director at Varex Imaging Corp.

Action: appointed
Role: Director

Exact text from the filing

appointed Kathleen L. Bardwell to serve on the Board for a term effective as of July 29, 2022

View on SEC.gov

Varex Imaging Corp filing history →

Source: SEC EDGAR

accession 0001681622-22-000061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.